Work

A recombinant anchorless respiratory syncytial virus (RSV) fusion (F) protein/monophosphoryl lipid A (MPL) vaccine protects against RSV-induced replication and lung pathology

Year: 2013

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2013.11.032

Authors: Jorge C.G. Blanco, Marina S. Boukhvalova, Lioubov M. Pletneva, Kari Ann Shirey, Stefanie N. Vogel

Institutions: Sigmovir Biosystems (United States), University of Maryland, Baltimore

Language: English

Topic: Respiratory viral infections research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institute of Allergy and Infectious Diseases

Awards: G1079889008, G255176686, G5769833972, DIFFERENTIATIVE SIGNALS FOR MACROPHAGE ACTIVATION, G6234954970, Development of VPL Vaccine for RSV, G6613926764, G7761731440

OpenAlex ID: W2015370918

FWCI: 2.654

Cites: 40

Cited by: 40

Related to: 10